Sanbaisuo Co., Ltd.

Legal Opinion from Beijing Zhonglun (Qingdao) Law Firm Regarding the 2025 Annual Shareholders' Meeting of Qingdao Sanbai Shuo Health Technology Co., Ltd.

Announcement on the Resolutions of the 2025 Annual Shareholders' Meeting

Announcement on the Appointment of the Company's General Manager

Announcement of Resolutions from the Fifteenth Meeting of the Second Board of Directors

Announcement on the Resignation of the General Manager

Qingdao Sanbo Health Technology Co., Ltd. announces that General Manager Mr. Wen Ke has resigned due to personal reasons, effective immediately. His resignation will not adversely affect the company's daily operations, and the board will expedite the appointment of a new general manager. Mr. Wen Ke does not hold company shares and has no outstanding commitments.

Announcement on Participating in the 2026 Qingdao Area Listed Companies Online Investor Day and 2025 Annual Performance Briefing

Qingdao Sanbai Shuo Health Technology Co., Ltd. will participate in an online investor event to communicate with investors about the company's governance, development strategy, and operating conditions. The event will be held on May 8, 2026, from 15:00 to 17:00. Investors can join via the "Quan Jing Lu Yan" website, WeChat official account, or APP.

Verification Opinion by CITIC Securities Co., Ltd. on Qingdao Sanbai Shuo Health Technology Co., Ltd.'s Use of Part of the Temporarily Idle Raised Funds for Cash Management

Announcement on the Use of Part of the Temporarily Idle Raised Funds for Cash Management

Announcement on the Use of Idle Own Funds for Investment and Financial Management for the Year 2026

Announcement on the Salary Scheme for Directors and Senior Management for the Year 2026

Special Verification Opinion on the Deduction of Operating Income for the Year 2025

Announcement on the Reappointment of the Accounting Firm for the Year 2026

Independent Director's Work Report for the Year 2025 (Luo Jie)

2025 Annual Independent Director's Performance Report (Bao Zai Shan)

This report details the performance of Independent Director Bao Zai Shan for the year 2025. The director diligently attended board and committee meetings, reviewed proposals, and provided objective opinions to protect shareholder interests. The director confirmed their independence and actively communicated with management and shareholders, contributing to the company's stable development and governance.

Independent Director's Work Report for the Year 2025 (Wang Yaping)

Internal Control Audit Report for the Year 2025

Self-Evaluation Report on Internal Control for the Year 2025

Compensation Management System for Directors and Senior Management (April 2026)

This document outlines the compensation management system for directors and senior management of Qingdao Sanboshuo Health Technology Co., Ltd. It details the principles of compensation, its composition, adjustment mechanisms, and assessment criteria, aiming to align compensation with company performance and individual contributions. The system ensures fairness, transparency, and a balance between incentives and accountability.

Announcement on the Provision for Asset Impairment for the Year 2025

CITIC Securities Co., Ltd. Special Audit Report on the Custody, Management, and Use of Raised Funds of Qingdao Sanbai Shuo Health Technology Co., Ltd. for 2025

This report by CITIC Securities Co., Ltd. audits the custody, management, and use of raised funds for Qingdao Sanbai Shuo Health Technology Co., Ltd. in 2025. It details fund inflow, usage for investment projects, and temporary supplementary liquidity. The report confirms fund compliance with regulations and management policies.

Verification Report on the Storage and Actual Use of Raised Funds for the Year

Verification Opinion by CITIC Securities Co., Ltd. on the Re-evaluation and Postponement of Some Investment Projects of Raised Funds for Qingdao Sanbai Shuo Health Technology Co., Ltd.

Announcement on the Re-evaluation and Postponement of Some Investment Projects of Raised Funds

Qingdao Sanbai Shuo Health Technology Co., Ltd. 2025 Annual Report on the Deposit, Management, and Use of Raised Funds

This report details the deposit, management, and use of raised funds for Qingdao Sanbai Shuo Health Technology Co., Ltd. in 2025. It outlines the initial capital raised, its allocation to investment projects, and temporary use for working capital. The report confirms the total net raised funds and their current balance as of December 31, 2025.

Verification Opinion by CITIC Securities Co., Ltd. on Qingdao Sanbai Shuo Health Technology Co., Ltd.'s Temporary Use of Part of the Idle Raised Funds to Supplement Working Capital

Announcement on the Temporary Use of Part of the Idle Raised Funds to Supplement Working Capital

Announcement on the Application for Credit Limits and Guarantees from Banks and Financial Institutions for the Year 2026

Announcement on Expected Related Party Transactions for the Year 2026

Feasibility Analysis Report on the Company's and Subsidiaries' Foreign Exchange Derivative Trading Business

Announcement on the Company and Its Subsidiaries Engaging in Foreign Exchange Derivative Transactions

The company and its subsidiaries will engage in foreign exchange derivative transactions to hedge against exchange rate and interest rate risks. The total transaction amount will not exceed USD 100 million or equivalent RMB, valid for 12 months from the 2025 annual shareholder meeting. This is not a related party transaction and will be funded by internal or self-raised funds.

Notice of the 2025 Annual General Meeting

Qingdao Sanbaishuo Health Technology Co., Ltd. will hold its 2025 Annual General Meeting on May 18, 2026, to review the 2025 annual report, profit distribution plan, and other proposals. Shareholders can vote in person or via online channels. The meeting will be held at the company's office.

Work Report of the Board of Directors for the Year 2025

Resolution Announcement of the 14th Meeting of the Second Board of Directors

Announcement on the Profit Distribution Plan for the Year 2025

Quarterly Report for the First Quarter of 2026

Evaluation Report on the Performance of the Accounting Firm for the Year 2025

Report on the Audit Committee's Supervision of the Accounting Firm for the Year 2025

Special Explanation on Non-Operating Fund Occupation and Other Related Party Fund Transactions for the Year 2025

Summary Table of Non-Operating Fund Occupation and Other Related Party Fund Transactions for the Year 2025

Special Opinion on the Board's Assessment of the Independence of Independent Directors

Audit Report for the Year 2025

Annual Report for the Year 2025

Summary of the Annual Report for the Year 2025

Announcement on the Progress of Using Part of the Temporarily Idle Fundraising Funds for Cash Management

Announcement on the Early Repayment of Idle Fundraising Funds for Temporary Supplementary Working Capital

Announcement on the Controlling Shareholder and its Concerted Parties' Share Reduction Reaching an Integer Multiple of 1% and the Completion of the Share Reduction Plan

Announcement on the Completion of Industrial and Commercial Change Registration by a Controlled Subsidiary

Announcement on the Controlling Shareholder and its Concerted Parties' Share Reduction Reaching an Integer Multiple of 1%

Announcement on the Completion of Transfer of Part of the Company's Shares by Shareholders Holding More Than 5% Through Agreement

Announcement on the Appointment of the Company's Board Secretary

Resolution Announcement of the Thirteenth Meeting of the Second Board of Directors